OpenAlex
PricingAboutJobs
Log inGet started
Author

D.T. Wai Meng

Institution: National Cancer Centre Singapore
Observed institution: National Cancer Centre Singapore
OpenAlex ID: A5083828324
LBA12 Efficacy of RLY-4008, a highly selective FGFR2 inhibitor in patients (pts) with an FGFR2-fusion or rearrangement (f/r), FGFR inhibitor (FGFRi)-naïve cholangiocarcinoma (CCA): ReFocus trial
2022 · A. Hollebecque, M. Borad, et al. · Annals of Oncology · 44
76MO Efficacy of RLY-4008, a highly selective FGFR2 inhibitor in patients (pts) with an FGFR2-fusion or rearrangement (f/r), FGFR inhibitor (FGFRi)-naïve cholangiocarcinoma (CCA): ReFocus trial
2022 · J.O. Park, D.T. Wai Meng, et al. · Annals of Oncology · 9
Works count: 2
Citation count: 53
H-index: 2
I10-index: 1
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security